ADVISORY ---FLASH---HEALTH-CORONAVIRUS/REMDESIVIR

WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients

Start: 16 Oct 2020 09:31 GMT

End: 16 Oct 2020 09:33 GMT

GENEVA, SWITZERLAND - WHO spokesman Tarik Jašarević reads statement on Gilead Sciences Inc's remdesivir having little or no effect on COVID-19 patients' length of hospital stay or chances of survival, according to a clinical trial by the World Health Organization (WHO).

Restrictions:

BROADCAST: NONE

DIGITAL: NONE

Source: REUTERS

Aspect Ratio: 16:9

Location: Switzerland

Topic: Science / Technology

Audio: NATURAL / ENGLISH

Editorial Support: +44 20 7542 2244

Email: tvnews@thomsonreuters.com